PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2008 2009
NEW/REPLACEMENT NARRATIVE
The FY 2009 COP Tuberculosis Control Assistance Program (TBCAP) builds on COP 08 and also
leverages $1.2 million in USAID Child Survival and Health TB funds. PEPFAR funding is used to support
collaborative TB/HIV activities, while USAID CSH funding continues to focus on strengthening the
foundation of TB prevention and control, in particular the continued roll out of community based DOTS to
Oshana, Oshikoto, Karas and Erongo regions.
The activities in the FY 2009 COP have been planned in close coordination and collaboration with other
USG partners, the Government of Namibia and the Global Fund.
USG partners participating in TBCAP are: CDC - strengthening NIP in quality assured sputum-smear,
culture and drug sensitivity testing, drug resistance surveillance, and counseling & testing; TB Infection
Control: I-TECH -training health workers on TB/HIV, MDR-TB, and developing a TB/HIV training for
community field promoters and supervisors: MSH/SPS - rational drugs management, regulation of new
additional second line drugs, monitoring of side-effects, prescription audits, public health evaluation;
Capacity Project - training, VCT, community-based DOTS; Development Aid from People to People
(DAPP): home based care; PACT - home based care; and the Global Fund - training health workers on
TB/HIV IEC, C&T for HIV in TB patients; training home-based-care workers on TB/HIV.
Coordination of these activities at all levels is still a major challenge for the Ministry of Health and Social
Services (MOHSS) National AIDS Control Program (NACOP) and National TB Control Program (NTCP),
exacerbated by a persistent shortage of human resources, including a lack of capacity in monitoring and
evaluation. FY 2009 COP funding will thus be used for the strengthening of coordination, management,
technical assistance, and development of technical policies.
A priority for TBCAP is thus strengthening leadership and management of the NTCP in all aspects of TB
control (in particular CB-DOTS, MDR-TB, TB-Infection Control, TB/HIV). To this end, COP 2009 will
enhance and expand communication and deliberations among program officers and staff through the
TBCAP-supported review meetings and TBHIV Committees at all levels. TBCAP will also support annual
TB/HIV meetings using the MSH Management and Organizational Sustainability Tool (MOST) model, a tool
(which was initiated in July 2007 for TB/HIV in Namibia.
The FY 2009 COP TB CAP program will concentrate on the following areas:
Coordination at all levels. TBCAP will strengthen coordination through the establishment and facilitation of
TB/HIV Coordinating Committee meetings at all levels on a quarterly basis, which should enable all
stakeholders in TB/HIV - both from a clinical and community perspective - to review progress and
challenges and develop remedial actions. Once yearly a TB/HIV MOST workshop will be organized at the
national level and in each region to ensure that planning and evaluation go hand-in-hand, and that activities
supported from all different funding streams are coordinated and well targeted.
Clinical management of patients dually treated for TB and AIDS (ART, CPT) will be reviewed at the health
facility level in clinical meetings through USG partners supporting TB treatment, HAART and HIV/AIDS
care. This review will be linked to clinical supervision supported by TB CAP, TB management in general,
and MDR-TB in particular. This activity will be sustained because it will be integrated into existing facility-
based Therapeutic Committees.
- TB/HIV IEC materials. This is a continuation from COP2008, but with co-funding from GFATM, will now
focus on re-printing and translating IEC materials into additional tribal languages for TB patients, PLWHA,
and the community. A new component is the development of short videos, leaflets, etc., aimed at raising
awareness of the rise in TB/HIV and how to take appropriate actions. The MOHSS will sustain these
activities once its recurrent budget for TB control is increased.
-TB Infection Control: This is a continuing activity but will be expanded to all hospitals and busy health
centers through: training existing Infection Control Officers on the prevention of TB nosocomial infection
using the new Namibian infection control guidelines; and site visits to conduct infection control assessments
and to supervise and monitor their implementation and monitoring and evaluation efforts. .
This will be done in close collaboration with anticipated continued support from CDC through visits by IC
specialists. Once existing infection control officers are trained in TB-IC and health facility infection control
plans are developed and implemented, MOHSS will sustain their enforcement.
Funding will also be set aside for purchasing N95 respirators. TB CAP has already worked with the NTCP
to make N95 masks available as part of the regular Central Medical Stores commodity and some
emergency protective clothing will also be procured. . TB-IC will thus become fully integrated in the national
IC policy and technical guidelines.
- MDR- TB Register. A new component of this activity is supporting the adjustment of an existing electronic
MDR-TB Register (developed by Stop-TB Partnership) for Namibia, in order to improve monitoring and
evaluation of MDR-TB management. Linkages to NIP data on drug resistant strains diagnosed in NIP will
also be pursued. This will be sustained by incorporating the TB information system into the existing MOHSS
HIS.
- Management of drug resistant TB: TB CAP will continue supporting programmatic management of drug
resistant TB through trainings; support supervisions and will fund quarterly clinical case review meetings.
These meetings will also strengthen surveillance of drug resistant TB.
-TBCAP will continue support for IPT through continued training of health workers who man ART clinics
using the TB/HIV module in the NTCP trainings; this activity is carried out in collaboration with I-TECH.
Support supervision for TB will also focus on ensuring smooth referral systems between TB clinics and ART
Activity Narrative: clinics and will also be rendered to ART, PMTC and VCT to ensure intensified case finding among PLWA.
Community NGOs working in HBC will continue to be invited for quarterly meetings to ensure they support
TB patients and also screen PLWA for TB as part of intensified case finding.
- Staff support. One medical doctor and one nurse will continue to be supported (as under COP2008) in the
TB ward in Katutura hospital to provide on-the-job and formal training of medical doctors and nurses on
MDR-TB management. These staff will also supervise the other seven MDR-TB admission centers and
conduct clinical audits, supporting M&E for MDR-TB.
- CB-DOTS coverage will be expanded within regions already supported by TBCAP. TBCAP will also
provide technical assistance to home based care NGOs such as DAPP to ensure that they include TB/HIV
collaborative issues into their activities;
- Increase TBCAP management capacity: FY 2009 COP funds will continue supporting a KNCV
Tuberculosis Foundation office in Windhoek. The office will comprise three resident medical officers, one of
which will be the project coordinator, who will provide hands-on technical assistance for implementation of
both USG and Global Fund work plans. They will be assisted by a financial controller and bookkeeper and
driver;
- Improve access to TB care: TBCAP will continue working with the Namibian government and other
partners to improve access to quality tuberculosis (TB) care for those infected with HIV & TB. All partners
will continue supporting one common goal as stipulated in TB Medium Term Plan I: to reduce tuberculosis
morbidity and mortality until TB is no longer a public health problem. Considerable progress has been made
in the past two years showing that funding and technical assistance from TBCAP is having an impact , also
allowing parallel efforts supported by Global Fund and WHO (Global Drug Facility) to bear fruit. The
continued rise in HIV testing among TB patients has been made possible through the continued support,
supervision and training in the new guidelines that incorporate TB/HIV activities. Given that almost 60% of
TB patients are HIV infected, TBCAP will strengthen prevention among positives through strengthening
health education messages in health facilities providing TB care.
New/Continuing Activity: Continuing Activity
Continuing Activity: 16210
Continued Associated Activity Information
Activity Activity ID USG Agency Prime Partner Mechanism Mechanism ID Mechanism Planned Funds
System ID System ID
16210 4436.08 U.S. Agency for Royal Netherlands 7379 3073.08 Tuberculosis $1,102,324
International Tuberculosis Control
Development Association Assistance
Program
8040 4436.07 U.S. Agency for Royal Netherlands 4411 3073.07 Tuberculosis $1,048,466
4436 4436.06 U.S. Agency for Royal Netherlands 3073 3073.06 $118,000
International Tuberculosis
Development Association
Emphasis Areas
Health-related Wraparound Programs
* Child Survival Activities
* TB
Human Capacity Development
Estimated amount of funding that is planned for Human Capacity Development $340,000
Public Health Evaluation
Food and Nutrition: Policy, Tools, and Service Delivery
Food and Nutrition: Commodities
Economic Strengthening
Education
Water
Table 3.3.12: